Prattes, Juergen http://orcid.org/0000-0001-5751-9311
Koehler, Philipp http://orcid.org/0000-0002-7386-7495
Hoenigl, Martin http://orcid.org/0000-0002-1653-2824
Wauters, Joost
Giacobbe, Daniele Roberto
Lagrou, Katrien
Salmanton-García, Jon
Rautemaa-Richardson, Riina
Hatzl, Stefan
Maertens, Johan
Debaveye, Yves
Bourgeois, Marc
Reynders, Marijke
Rutsaert, Lynn
Van Regenmortel, Niels
Lormans, Piet
Feys, Simon
Reisinger, Alexander Christian
Cornely, Oliver A.
Lahmer, Tobias
Valerio, Maricela
Delhaes, Laurence
Jabeen, Kauser
Steinmann, Joerg
Chamula, Mathilde
Bassetti, Matteo
,
Article History
Received: 16 August 2021
Accepted: 16 August 2021
First Online: 1 September 2021
Declarations
:
: JP has received personal fees from Gilead Sciences and Pfizer, research funding from MSD and is stoke holder of AbbVie Inc and Novo Nordisk. PK is supported by the German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany and has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany, and received lecture honoraria from and/or is advisor to Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., and University Hospital, LMU Munich outside the submitted work. MH received research funding from Gilead Sciences, Astellas, Scynexis, F2G and Pfizer.
Free to read: This content has been made available to all.